Cargando…
Pediatric drug development : concepts and applications /
Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other no...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Chichester, West Sussex, UK :
Wiley Blackwell,
2013.
|
| Edición: | Second edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn910720322 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 130206s2013 enk ob 001 0 eng | ||
| 010 | |a 2013005181 | ||
| 040 | |a DLC |b eng |e pn |c DLC |d MHW |d N$T |d YDXCP |d DG1 |d CUI |d STF |d OCLCF |d NLGGC |d VLB |d EBLCP |d OCLCQ |d DEBBG |d D6H |d DG1 |d CHVBK |d LIP |d ZCU |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d OCLCQ |d CASUM |d OCLCO |d ICG |d VT2 |d OCLCO |d AU@ |d OCLCO |d WYU |d OCLCQ |d OCLCO |d OCLCA |d OCLCQ |d DKC |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 019 | |a 827010652 |a 992928934 | ||
| 020 | |a 9781118312056 |q (ePub) | ||
| 020 | |a 1118312058 |q (ePub) | ||
| 020 | |a 9781118312063 |q (MobiPocket) | ||
| 020 | |a 1118312066 |q (MobiPocket) | ||
| 020 | |a 9781118312131 |q (Adobe PDF) | ||
| 020 | |a 1118312139 |q (Adobe PDF) | ||
| 020 | |a 9781118312087 | ||
| 020 | |a 1118312082 | ||
| 020 | |z 9781118312155 |q (cloth) | ||
| 029 | 1 | |a AU@ |b 000060217364 | |
| 029 | 1 | |a CHNEW |b 000944393 | |
| 029 | 1 | |a CHVBK |b 480246270 | |
| 029 | 1 | |a DEBBG |b BV042795505 | |
| 029 | 1 | |a DEBBG |b BV043397857 | |
| 029 | 1 | |a DEBBG |b BV044175823 | |
| 029 | 1 | |a DEBSZ |b 485058960 | |
| 029 | 1 | |a GBVCP |b 790209187 | |
| 029 | 1 | |a NZ1 |b 15341511 | |
| 035 | |a (OCoLC)910720322 |z (OCoLC)827010652 |z (OCoLC)992928934 | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a RJ560 |
| 060 | 4 | |a QV 771 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 082 | 0 | 0 | |a 615/.190083 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Pediatric drug development : |b concepts and applications / |c [edited by] Andrew E. Mulberg, Dianne Murphy, Julia Dunne, Lisa L. Mathis. |
| 250 | |a Second edition. | ||
| 264 | 1 | |a Chichester, West Sussex, UK : |b Wiley Blackwell, |c 2013. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 520 | |a Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development. | ||
| 505 | 0 | |a pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Pediatric pharmacology. | |
| 650 | 0 | |a Drug development. | |
| 650 | 0 | |a Children. | |
| 650 | 0 | |a Age factors in disease. | |
| 650 | 1 | 2 | |a Child |
| 650 | 1 | 2 | |a Drug Evaluation |x methods |
| 650 | 2 | 2 | |a Age Factors |
| 650 | 2 | 2 | |a Clinical Trials as Topic |x standards |
| 650 | 2 | 2 | |a Drug Evaluation |x ethics |
| 650 | 2 | 2 | |a Drug Evaluation |x standards |
| 650 | 6 | |a Pharmacologie pédiatrique. | |
| 650 | 6 | |a Médicaments |x Développement. | |
| 650 | 6 | |a Enfants. | |
| 650 | 6 | |a Maladies |x Facteurs liés à l'âge. | |
| 650 | 7 | |a children (people by age group) |2 aat | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a Children |2 fast | |
| 650 | 7 | |a Age factors in disease |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Pediatric pharmacology |2 fast | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Mulberg, Andrew E., |e editor. | |
| 700 | 1 | |a Murphy, M. Dianne, |e editor. | |
| 700 | 1 | |a Dunne, Julia, |d 1954- |e editor. | |
| 700 | 1 | |a Mathis, Lisa L., |e editor. | |
| 758 | |i has work: |a Pediatric drug development (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGjtcbBCGfY8XcdpckmC43 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Pediatric drug development. |b Second edition. |d Chichester, West Sussex : John Wiley & Sons Inc., 2013 |z 9781118312155 |w (DLC) 2013004158 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1204055 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4034055 | ||
| 938 | |a EBSCOhost |b EBSC |n 588006 | ||
| 938 | |a YBP Library Services |b YANK |n 9984393 | ||
| 938 | |a YBP Library Services |b YANK |n 10745707 | ||
| 994 | |a 92 |b IZTAP | ||